
Associate Director, US Oncology Marketing Portfolio Strategy, Sac-TMT
Merck
Summary
Our Oncology team is dedicated to delivering breakthrough innovations that extend and improve the lives of cancer patients worldwide, with a focus on launch excellence. We are currently recruiting for an Associate Director, US Oncology Marketing Portfolio Strategy for the US Oncology sac-TMT Portfolio Strategy & Capabilities Team.
Job description
This role leads cross-tumor key account and portfolio strategy for sac-TMT, an asset with multiple anticipated indications. It drives integrated account and portfolio planning, strategic forecasting, and investment prioritization, and leads the Objectives & Key Results (OKR) process and Tri-semester Business Reviews (TBRs) across the brand.
Primary Responsibilities
Key Account and Portfolio Strategy
- Lead sac-TMT key account strategy, developing integrated cross-tumor account plans with organized customer, key account, and tumor teams to ensure a consistent presence and avoid duplication or gaps.
- Translate insights from health systems, integrated delivery networks, and large oncology practices into portfolio priorities and pull-through plans as new indications are added.
- Lead integrated portfolio planning, bringing tumor-level plans together into a cohesive asset-level strategy, timeline, and resource view, including U.S. HCP Masterbrand integration across tumor teams.
- Monitor the evolving treatment landscape, clinical programs, and competitive activity across sac-TMT tumor types to inform portfolio positioning and sequencing.
Strategic Forecasting and Investment Prioritization
- Consolidate tumor-level forecasts and budgets with Finance and Forecasting, and build scenario plans that reflect launch timing and its impact on resourcing and investment.
- Monitor spend and variances across sac-TMT, flagging risks and opportunities to leadership.
- Lead preparation for portfolio prioritization and governance forums, including investment trade-off analyses across tumors, channels, and shared capabilities, and ensure decisions are reflected in tumor plans and budgets.
Performance Insights and Cross-Functional Leadership
- Lead the sac-TMT objectives and key results (OKR) process and Tri-semester Business Reviews (TBRs) across the brand, setting asset-wide OKRs with tumor teams and running the review cadence that tracks progress, surfaces risks, and drives corrective action.
- Maintain the performance dashboard with Data and Analytics, and synthesize results across tumor types into recommendations and the sac-TMT strategic narrative for senior leaders, business reviews, and long-range planning.
- Build alignment across Marketing, Finance, Market Access, Organized Customer, Medical Affairs, Analytics, Global Marketing, and Sales stakeholders to foster a collaborative, data-driven culture.
Education Minimum Requirement
Bachelor's degree required; advanced degree (MBA, PharmD, PhD, MPH, or equivalent) preferred.
Required Experience and Skills
- Minimum five years of experience in the pharmaceutical, biotechnology, or healthcare industry, including marketing, key account or organized customer strategy, forecasting, or commercial strategy.
- Demonstrated experience with brand or portfolio planning, budget management, and resource allocation or investment prioritization in partnership with Finance.
- Strong analytical and strategic thinking skills, with the ability to turn complex data into clear recommendations.
- Demonstrated ability to lead without authority, drive alignment across matrix organizations, and communicate and present effectively to senior leaders.
- Experience navigating Legal, Regulatory, and Medical review processes while managing multiple priorities and critical milestones.
Preferred Experience and Skills
- U.S. Oncology marketing and multi-indication or portfolio strategy experience.
- Experience with key accounts, organized customers, integrated delivery networks, or health-system strategy.
- Experience building OKR or KPI frameworks and performance dashboards, and leading business reviews.
- Market Access, Finance, Forecasting, or Commercial Analytics experience.
Position Location
Upper Gwynedd, PA (hybrid work model) OR USA Remote
Requirements
- Bachelor's degree required
- Minimum five years of experience in the pharmaceutical, biotechnology, or healthcare industry
- Experience in marketing, key account or organized customer strategy, forecasting, or commercial strategy
- Demonstrated experience with brand or portfolio planning, budget management, and resource allocation or investment prioritization in partnership with Finance
- Strong analytical and strategic thinking skills
- Ability to turn complex data into clear recommendations
- Demonstrated ability to lead without authority and drive alignment across matrix organizations
- Ability to communicate and present effectively to senior leaders
- Experience navigating Legal, Regulatory, and Medical review processes
- Budget Management
- Cross-Functional Leadership
- Customer Centricity
- Data-Driven Decision-Making
- Executive Presence
- Financial Acumen
- Key Account Management
- Marketing Performance Analytics
- Organized Customer Strategy
- Portfolio Prioritization
- Strategic Planning
Benefits
- Medical, Dental & Vision
- Retirement Benefits
- 401(k)
- Paid Holidays
- Vacation
- Compassionate Leave
- Sick Days
- Annual Bonus
- Long-Term Incentive
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.